We are live on ! Find out more
INBX

Inhibrx, Inc. Common Stock
INBX

Delisted

INBX was delisted on the 29th of May, 2024.

Back to rankings

2 hedge funds and large institutions have $1.16M invested in Inhibrx, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 123 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% less funds holding

Funds holding: 126 → 2 (-124)

100% less capital invested

Capital invested by funds: $1.34B → $1.16M (-$1.34B)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 123

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-124
Holders Change %
-98.41%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
123
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
-$250M
2
PA
Perceptive Advisors
New York
-$149M
3
BlackRock
BlackRock
New York
-$96.2M
4
RCM
RA Capital Management
Massachusetts
-$91.9M
5
State Street
State Street
Massachusetts
-$84.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
51
Birchview Capital
Vermont
– -$1.69M -48,448 Closed
PHS
52
PFM Health Sciences
California
– -$1.68M -47,918 Closed
Marshall Wace
53
Marshall Wace
United Kingdom
– -$1.53M -43,678 Closed
Swiss National Bank
54
Swiss National Bank
Switzerland
– -$1.47M -42,000 Closed
NYLIM
55
New York Life Investment Management
New York
– -$1.43M -40,976 Closed
AllianceBernstein
56
AllianceBernstein
Tennessee
– -$1.25M -35,860 Closed
AGM
57
Alpine Global Management
New York
– -$1.22M -35,000 Closed
AA
58
ALPS Advisors
Colorado
– -$1.17M -33,431 Closed
PA
59
Profund Advisors
Maryland
– -$1.1M -31,335 Closed
HWAM
60
Hennion & Walsh Asset Management
New Jersey
– -$1.07M -30,561 Closed
UBS AM
61
UBS AM
Illinois
– -$1.03M -29,580 Closed
Jane Street
62
Jane Street
New York
– -$920K -26,314 Closed
Millennium Management
63
Millennium Management
New York
– -$878K -25,110 Closed
California State Teachers Retirement System (CalSTRS)
64
California State Teachers Retirement System (CalSTRS)
California
– -$790K -22,593 Closed
Mirae Asset Global Investments
65
Mirae Asset Global Investments
South Korea
– -$537K -21,920 Closed
M&T Bank
66
M&T Bank
New York
– -$751K -21,476 Closed
Legal & General Group
67
Legal & General Group
United Kingdom
– -$726K -20,765 Closed
AW
68
Alaethes Wealth
Nevada
– -$676K -19,341 Closed
State of Wisconsin Investment Board
69
State of Wisconsin Investment Board
Wisconsin
– -$660K -18,866 Closed
MIM
70
MetLife Investment Management
New Jersey
– -$636K -18,194 Closed
AIG
71
American International Group
New York
– -$592K -16,926 Closed
ProShare Advisors
72
ProShare Advisors
Maryland
– -$585K -16,741 Closed
FC
73
FORA Capital
Florida
– -$563K -16,103 Closed
BMCM
74
Black Maple Capital Management
Wisconsin
– -$555K -15,863 Closed
T. Rowe Price Associates
75
T. Rowe Price Associates
Maryland
– -$518K -14,812 Closed
1 2
3
4 5

INBX Hedge Fund Activity: Q2 2024 in Review

2 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Inhibrx, Inc. Common Stock (INBX) for Q2 2024, worth a combined $1.16M — down 100% from $1.34B a quarter earlier.

Sellers outnumbered buyers: 123 funds closed out of INBX and 0 opened new positions — a net loss of 123 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Viking Global Investors, exiting entirely with an estimated $250M sold.

  • 2 institutional investors held Inhibrx, Inc. Common Stock (INBX) as of Q2 2024, down from 126 in Q1 2024.
  • Funds reported $1.16M of Inhibrx, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Inhibrx, Inc. Common Stock positions in Q2 2024 and 123 closed out, a net change of -123 holders.
  • The largest Inhibrx, Inc. Common Stock seller in Q2 2024 was Viking Global Investors, an estimated $250M sold.

Based on aggregated 13F filings for Q2 2024.